| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |